Amelia Fletcher Chief Economist Office of Fair Trading

Slides:



Advertisements
Similar presentations
CHAPTER 1 Basic Concepts of Strategic Management
Advertisements

Cost Management ACCOUNTING AND CONTROL
Chapter 9 Growth.
International Business 9e
Fourth Global Congress on Combating Counterfeiting and Piracy WIPO Development Agenda: a New Global Initiative Dubai February 3 to 5, 2008 Pushpendra Rai.
Elderly participation in European Health policy and Patients Rights Teresa Petrangolini ACN Director.
SCIENCE,SUSTAINABLE AGRICULTURE AND RURAL DEVELOPMENT IN THE E.U.
Impact of JUSFTA on affordability and availability of medicines from perspective of local generic manufacturers Towards equitable and affordable medicine.
GREETINGS TO CHARTERED ACCOUNTANTS FOR ICAIS POST QUALIFICATION COURSE VIDEO CONFERENCE FROM HYDERABAD 26 AUGUST 2005.
GREETINGS TO CHARTERED ACCOUNTANTS FOR ICAIS POST QUALIFICATION COURSE VIDEO CONFERENCE FROM HYDERABAD 26 AUGUST 2005.
Competition policy in the WTO: an introduction to the issues Robert D. Anderson Counsellor, WTO Secretariat WTO Public Symposium on Multilateralism at.
Hamid Dom Reg WS March 04 1 INTRODUCTION THE GATS and DOMESTIC REGULATION.
Differential Pricing: Reconciling R&D, IP and Access Patricia M. Danzon PhD The Wharton School University of Pennsylvania.
1 SPORT AND COMPETITION LAW AT EU LEVEL Madrid, february 2007 MICHELE COLUCCI
DG Education and Culture New generation of programmes Marco DI MARTINO Information officer Athens, 7 December 2006.
Dubai Conference May 2004 Molengraaff Institute Center for Intellectual Property Law (CIER) 2 OVERVIEW Domain Concepts Methodologies Problematic Issues.
University Industry Relation (in open innovation era) Kazuyuki Motohashi Professor, Department of Technology Management for Innovation, The University.
Dr. Kajit Sukhum Assistant Director General International Affair DEPARTMENT OF INTELLECTUAL PROPERTY THAILAND IP PANORAMA IN THAILAND.
1 Enforcement Powers of National Data Protection Authorities and Experience gained of the Data Protection Directive Safe Harbour Conference Washington.
IMPACT ESTIMATION PROJECT h o r i z o n s c a n n i n g Anti-trust issues in on-line retailing Ed Smith Director Office of Fair Trading The views expressed.
McGraw-Hill/Irwin Copyright © 2013 by The McGraw-Hill Companies, Inc
Slide 1 Design in Innovation Coming out from the Shadow of R&D Bruce Tether Centre for Research on Innovation & Competition and Manchester Business School,
Vision: A strong and capable civil society, cooperating and responsive to Cambodias development challenges 1.
What you will learn in this chapter:
1 Competition Law and Policy Workshop March 30-31, 2011 Savannah Hotel.
Munich Intellectual Property Law Center (MIPLC) Intellectual Property and Clean Technology in the context of the European Legal Framework Marisa Aranda.
Foundations of Chapter M A R K E T I N G Copyright © 2003 by Nelson, a division of Thomson Canada Limited. Understanding Pricing 13.
Chapter foundations of Chapter M A R K E T I N G Understanding Pricing 13.
Key Issues for the Competition Policy Review Professor Ian Harper Chair, Competition Policy Review Panel UNSW, 6 August 2014.
Global Entrepreneurship and Small Business Management
Women in the Digital Economy Dr Patrice Braun Centre for Regional Innovation & Competitiveness.
Global E-Commerce Back to Table of Contents.
1 Insights on cross-border ex ante controls – Polish experiences 27th Conference of Directors of EU Paying Agencies Oviedo, April 2010.
Patent settlements in the EU EGA perspective Ingrid Vandenborre 18 October 2013.
1 Review of the EU regulatory framework for electronic communications Stephen Banable European Commission DG Information Society and Media ITU Conference.
1 A. Introduction 1.Object of study: firms, markets and systems; structures and behaviour 1.1. Object of the Firm and Industrial Economics 1.2. Basic concepts.
International Opportunities
Foundations of Chapter M A R K E T I N G Copyright © 2003 by Nelson, a division of Thomson Canada Limited. Global Marketing 20.
NORMAPME ISO User Guide for European SMEs The essence of.
What is Business? © 2007 The McGraw-Hill Companies, Inc., All Rights Reserved. McGraw-Hill/Irwin Introduction to Business Chapter One.
COMPETITION POLICY AND ECONOMIC DEVELOPMENT PRESENTATION AT CUTS-ARC CAPACITY BUILDING WORKSHOP, LUSAKA 7 TH MARCH, 2011 BY SAJEEV NAIR, COMPETITION POLICY.
The European Commission's proposal for a draft directive on the collective management of rights Towards the reform of collective rights management and.
RECOMMENDATIONS BY INTELLECTUAL PROPERTY LAWYERS ON LEGAL REFORM MOSES NKOMO LL.B, MIP.
The fundamentals of EC competition law
Monti II Regulation and Enforcement Directive on Posting of Workers CBSP Committee 7 November 2012 Jorma Rusanen.
National symposium on Competition law: Evolution and Transition, 2012 Competition Policy for IP Issues Pradeep S Mehta Secretary General, CUTS International.
1 Is there a conflict between competition law and intellectual property rights? Edward Whitehorn Head, Competition Affairs Branch Carrie Tang Assistant.
Introduction to EU Law Cont.d. ECJ – TFI (Arts ) “The Court of Justice and the Court of First Instance, each within its jurisdiction, shall ensure.
What the government does A2 Economics and Business Unit 4B By Mrs Hilton for revisionstation.
“Equal and open access to the market in terms of economic integration and increased competition ” Astana Forum, 24 May 2013 Presented by Hassan Qaqaya,
The UK competition regime: an example of inter-institutional working Cathryn Ross Deputy Director of Remedies Competition Commission 2 February 2004.
H I R S C H & P A R T N E R S A v o c a t S o l i c i t o r R e c h t s a n w a l t Pharmaceutical settlement agreements and competition law A litigation.
Benefits of Product Market Competition National Training Workshop on Competition Policy and Law Gerald Gregory (CUTS Fellow)
STRUCTURE AND FUNCTIONS OF COMPETITION AGENCIES. GENERAL STRUCTURE OF CA CAs differ in size, structure and complexity The structure depicts power distribution.
Introductory course on Competition and Regulation Pál Belényesi University of Verona October 2006.
Competitiveness of the European-based Pharmaceutical Industry Prospective of a New Member State Imre Hollo Deputy Secretary of State, MOH Hungary.
CANTO 24th Annual Seminar Enhancing competitiveness in the Caribbean through the harmonization of ICT policies, legislation and regulation Bahamas, July.
1 FRAND COMMITMENTS AND EU COMPETITION LAW Thomas Kramler European Commission, DG Competition (The views expressed are not necessarily those of the European.
Reporting to Stakeholders. What are Stakeholders? An individual or group with an interest in an organisation An individual or group with an interest in.
Merger Control in Uruguay American Bar Association- South American Regional Conference Buenos Aires, March, 2007 Guyer & Regules Juan Manuel Mercant.
INVESTIGATION AND ENFORCEMENT Presentation by Duncan T. Morotsi 15 th March
ABA China Inside and Out September , Beijing The interface between competition law and intellectual property Nicholas Banasevic, DG Competition,
Chapter 3 Benefits of a Free Enterprise Section 1 and 2.
The Economic Environment of Business – Lecture 5 Competition Policy.
Competition Law Understand the legal rules relating to monopolies, mergers and anti-competitive practices.
European Union Law Week 10.
EU Competition Rules for Technology Transfer Agreements
Lesson Objectives All students will understand the importance of regulation in some markets Most students will be able to assess the why the regulation.
Competition Policy: Definition and Scope
COMPETITION POLICY AND IP
Presentation transcript:

Amelia Fletcher Chief Economist Office of Fair Trading IP and the role of National Competition Authorities: A perspective from the OFT Amelia Fletcher Chief Economist Office of Fair Trading 1

Introduction Some views on the IP/competition law interface, and hot issues The role of the OFT The OFT’s work to date with an IP dimension The role of NCAs such as the OFT with respect to IP

The treatment of IP by competition authorities: some traditional views? “I might just as well use this patent as wallpaper if competition law won’t let me enforce it” An anonymous patentee (attrib)

From...worlds in collision... “Intellectual Property and Competition Law: When Worlds Collide” Paper by Donald M Cameron, 1997 Annual Canadian Bar Association Competition Law Conference

...to....happy marriage? “It is of course a longstanding topic of debate in economic and legal circles how to marry the innovation bride and the competition groom. In the past some have argued that such a marriage will unavoidably lead to divorce because of conflicting aims of IPR law and competition law. But I think that by now most will agree that for a dynamic and prosperous society we need both innovation and competition. Contrary to what some might think, competition is a necessary stimulus for innovation. IPR law and competition law have a complementary role to play in promoting innovation to the benefit of consumers. I therefore firmly belief in this marriage and, like in all good marriages, the real question is how to achieve a good balance between both policies.” Former EU Commissioner of Competition Mario Monti speaking in Paris, on 16 January 2004

Some hot issues in the IP and competition law interface

Some hot issues in the IP and competition law interface

Where the does the OFT come in? Mission is to make markets work well for consumers Work consists of: Enforcing competition law Enforces the Competition Act 1998 (CA98) (and where there is an effect on trade between EU Member States, Articles 101 and 102 of the Treaty on the Functioning of the European Union) Merger control Analysing markets Competition advocacy Enforcing consumer law

Where does the OFT come in? IP is an area of focus for the OFT in its annual plan: “We also propose to take forward work on intellectual property rights (IPRs) which, by safeguarding product or service differentiation and driving innovation, are an essential part of ensuring strong competition and economic growth. Competition and consumer policy can be an important complement to IPRs in driving innovation. Where appropriate, they can also ensure that IPRs are not exercised in a manner that acts against the interests of consumers.” Page 19 of the 2012-2013 Annual Plan

OFT activity with an IP and innovation dimension to date No CA98 infringement decisions specifically concerned with the existence or exercise of IP However, a number of OFT Chapter II infringement decisions have related to the pharmaceutical sector, where IP issues have had to be considered Napp anti-competitive pricing strategies for pharmaceutical product, post-patent expiry Genzyme: margin squeeze with respect to pharmaceutical product Gaviscon finding withdrawal of Gaviscon Original Liquid with the intention of limiting pharmacy choice and hindering competition from suppliers of generic medicines, post-patent expiry (effective patent extension) Also an ongoing case under Chapter I, considering allegation of “pay for delay” in the pharmaceutical sector 10

OFT activity with an IP and innovation dimension to date “At the Races” collective selling of certain media rights infringement decision annulled by the Competition Appeal Tribunal 11

OFT activity with an IP and innovation dimension to date And note, where the OFT has not taken action under CA98: For example, BSI (2003) The British Standards Institution granted an online licence to Barbour Index plc following an investigation by the OFT into an alleged abuse of a dominant position. Barbour Index had alleged that BSI was breaching the Competition Act by refusing to grant it a licence to supply BSI standards online. The OFT closed its case without reaching any conclusion on whether BSI holds a dominant position or has abused any such position. 

OFT activity with an IP and innovation dimension to date OFT advocacy work: Commercial Use of Public Information market study (2006) Found that more competition in public sector information could benefit the UK economy by around £1 billion a year. Made recommendations, including that public sector information holders should: make as much public sector information available as possible for commercial use/re-use ensure that businesses have access to public sector information at the earliest point that it is useful to them

OFT activity with an IP and innovation dimension to date OFT advocacy work: Pharmaceutical Price Regulation Scheme (PPRS) market study (2007) Recommended that the current 'profit cap and price cut' scheme should be replaced with a patient focused value based pricing scheme in which the prices the NHS pays for medicines reflect the therapeutic benefits they bring to patients. This would enable the NHS to obtain greater value for money from its existing drug spend and furthermore, encourage innovation

OFT activity with an IP and innovation dimension to date Considerable work on mergers…for example: Princes/Premier (clearance – involved branded, own-label canned foods, divestments of the Fray Bentos brand) SUP Amisco/Prozone (clearance – pace of dynamic innovation overcoming any concern about concentration) GSK/Pfizer (clearance – though key overlaps with respect to innovation rather than product) Project Kangaroo (referred by OFT to CC – blocked – video on demand (VOD) joint venture)

OFT activity with an IP and innovation dimension to date Analysis of mergers in nascent and/or innovative sectors has tended to trade off: the likelihood of new entry into a new, fast-moving sector.... against the risk that the merger may ‘tip’ the market one way or the other

Striking the right balance It is well known that holding an IP right does not confer immunity from competition law intervention However OFT is equally alert to the need for caution when considering competition interventions dealing with IP Do not wish to undermine incentives for innovation

Striking the right balance Focus on removing anti-competitive obstacles to innovation Focus on dynamic competition, rather than static competition Consider in particular innovation markets Particular interest in ensuring that incumbents do not prevent new business models from developing What matters is the aggregate amount of inventive activity, not the identity of individual innovators

IP is global National competition authorities such as the OFT need to ensure that they are well placed when considering IP cases, in terms of being able to obtain evidence and to impose effective remedies Anti-competitive pan-national IP strategies therefore tend be better addressed by pan-national enforcement And note provisions on case allocation in ECN notice on co-operation in the network of competition authorities Where agreement or conduct affects more than three member states, then European Commission particularly well placed to deal

IP is global So…is a National Competition Authority such as the OFT well placed to deal with issues in a global “patent war”? Or better placed to deal with IP and competition issues having a particular focus on, or centre of gravity in, the UK

Some potential areas of interest... These could include: IP and competition questions arising from distribution issues with a UK-focus Particular interest in issues arising from brands... Note merger decisions, such as Princes/Premier Internet retailing and selective distribution Consider application of Vertical Agreements Block Exemption Regulation and guidelines For example, issues relating to the on-line pricing of branded goods OFT is attentive to the trade-offs between brand protection and competition

Some potential areas of interest OFT recognises IP system has built-in safeguards, for example: strict novelty, inventive step, disclosure requirements required for grant of patent, and opportunity for counterclaim for revocation in patent litigation BUT, competition authorities can have a role in dealing with anti-competitive means of subverting these safeguards Consider, for example, improperly obtained IP Compare situation in US anti-trust law with respect to “fraud on the Patent Office” And note EU cases (AstraZeneca under Article 102 (under appeal, AG’s opinion on 12 May 2012)) Or “pay for delay” allegations with respect to pharma patents

Merger control Merger control is potentially very important Many mergers are below EU notification thresholds Focus is on overlaps and prospective effects of merger on competition Could involve smaller, innovative businesses with IP and technology in fast-growing markets Which are therefore below the EU thresholds Might also involve transactions involving “Non-Practicing Entities” Consider impact on innovation Potential for packages of IP rights to constitute an ‘enterprise’ under UK merger law?

Markets work OFT can conduct market studies with IP dimension Note also the potential effectiveness of suitable market interventions in domestic markets with an IP dimension... Consider for example, section 176 of the Broadcasting Act 1990 (BA90) Requiring certain broadcasters to provide advance information about their programming to publishers And provisions allowing reproduction of that information (for example, Schedule 17 of the BA90) Arose from an 1985 MMC report (Cmd 9614) ...compare Magill....

Note too, advocacy OFT will engage with IP policy makers to ensure effective consideration of competition issues in the IP space And vice versa OFT to engage with the European Commission on the new Technology Transfer Block Exemption Regulation Ongoing engagement between the IPO and the OFT OFT welcomes the competition focus of the Hargreaves report IPO and OFT have been in discussions about working together more effectively will shortly set out how we will do this - watch this space!

So, in conclusion...with IP and competition, we want to help facilitate:

Rather than...

And now...